Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Translate Bio to Present at Upcoming Investor Conferences | ||||||||||||||
By: GlobeNewswire - 19 Feb 2020 | Back to overview list |
|||||||||||||
LEXINGTON, Mass, Feb. 19, 2020 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction, today announced that Ronald Renaud, chief executive officer, will present a corporate overview at the following upcoming investor conferences:
A live webcast of each presentation will be accessible through the “Events and Presentations” page of the Company's website at investors.translate.bio. A replay of the webcast will be archived on the Translate Bio’s website for 30 days following the presentation. About Translate Bio Contacts for Translate Bio
|
||||||||||||||
|
||||||||||||||
Copyright 2020 GlobeNewswire | Back to overview list |